Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in local currency (LC) terms, compared ...
Honored “for incredible work using technology to combat social isolation,” this marks ONSCREEN’s third CES award in ...
Those with vision or hearing challenges, people who struggle with dexterity and fine motor skills, in particular, may find ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, today announced a $1.5 million, three-year grant to Blue Circle Health, a nonprofit providing free, ...
DENVER, CO / / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous ...
DENVER, CO / / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous ...
Research has linked it to higher risks of multiple major cardiovascular conditions, even if you exercise, eat well and get ...
Jellies & Gummies Market to reach US$ 13.0 Bn by 2036 at 4.2% CAGR, driven by rising demand for functional gummies, adult ...
Finland issues new national digital guidelines for children, advising against smartphones and social media for under-13s and ...
From sleep, anxiety to vitamin deficiencies, there seems to be a squishy, tasty solution for them all. But doctors sound a ...
Like most new parents, Ahad and Hira Ul Hassan keep a close eye out for signs that their one-year-old son Zohan is developing just as he should.
DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central n ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results